Chuang-Hsin Chiu

Tri-Service General Hospital

Papers

1

Total Citations

6

H-Index

1

About

Chuang-Hsin Chiu is a leading molecular imaging scientist whose work bridges radiochemistry and neuroinflammation research. Her primary research areas include positron emission tomography (PET) tracer development, neuroinflammatory biomarker imaging, and theranostic probe design. Dr. Chiu’s major contribution lies in pioneering the automated synthesis of novel radiotracers targeting inducible nitric oxide synthase (iNOS), a critical enzyme in microglial activation and neuroinflammation. Her landmark 2021 study introduced a first-in-class spiroquinazolinone-based PET/MR imaging agent, demonstrating a strategic framework for non-invasively visualizing iNOS expression in the brain. This work, which has garnered 6 citations, represents a significant step toward early diagnosis and monitoring of neurodegenerative diseases. Dr. Chiu’s innovative approach combines sophisticated organic synthesis with translational imaging, enabling real-time tracking of neuroinflammatory processes. Her achievements have positioned her at the forefront of developing molecular tools that could transform how researchers study conditions like Alzheimer’s and multiple sclerosis. By creating targeted probes that bridge chemistry and clinical imaging, she continues to advance the frontier of precision medicine in neurology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Automated Synthesis and Initial Evaluation of (4′-Amino-5′,8′-difluoro-1′H-spiro[piperidine-4,2′-quinazolin]-1-yl)(4-[ <sup>18</sup> F]fluorophenyl)methanone for PET/MR Imaging of Inducible Nitric Oxide Synthase
6 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Tri-Service General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago